… Common detection methods in practice for diagnosing colorectal cancer (CRC) are painful
… simple potential use in developing a flexible CRC treatment to the patient’s potential benefits …

… Piwi-interacting RNA (piRNA) is one of the noncoding RNAs, … the potential of piRNA in the
diagnosis and treatment of … of piRNAs as potential therapeutic targets through in vivo and in …

… MiR-4510 is identified as an oncogene in many cancers, and has been verified to participate
in … prognosis and EMT, which provides a promising therapeutic target for further treatment. …

… treatment and a cause of tumor relapse, with the underlying molecular mechanism still unknown.
PIWI-interacting … in colorectal cancer and played an oncogenic role. piR-823 promoted …

… diagnostic and prognostic biomarkers and therapeutic targets. … led to augmentation of
oncogenic properties in vitro and in … cancer by targeting miR-21 [245] or in colorectal cancer …

… To achieve the early diagnosis of NSCLC, we investigated serum-derived Piwi-interacting …
Lung, breast, liver, gastric, and colorectal cancers are the top five cancers related to death …

… PIWI-interacting RNAs (piRNA) in patients with endometriosis. Similarly, no data are available
about piRNAs as potential … and/or deep endometriosis with colorectal involvement All the …

… therapy. These studies emphasize the potential of noncoding RNAs as therapeutic targets
… 7 and makes it less available to its target oncogenes. This increases later expression, which …

… , core pathways and potential functional networks in colorectal cancer, suggesting that
TYMS and BCL2L1 may become new prognostic and therapeutic targets for colorectal cancer. …

Aims: We aimed to measure the abundance of Fusobacterium nucleatum (F. nucleatum) in
colorectal cancer (CRC) tissues from patients and to uncover the function of this bacterium in …